Cochrane Abstracts
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus: Cochrane systematic review
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Dipeptidyl-peptidase (DPP)-4 Inhibitors and Glucagon-like Peptide (GLP)-1 Analogues for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in People at Increased Risk for the Development of Type 2 Diabetes Mellitus: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438410/all/Dipeptidyl_peptidase__DPP__4_inhibitors_and_glucagon_like_peptide__GLP__1_analogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus:_Cochrane_systematic_review. Accessed 02 March 2021.
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438410/all/Dipeptidyl_peptidase__DPP__4_inhibitors_and_glucagon_like_peptide__GLP__1_analogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus:_Cochrane_systematic_review. Accessed March 2, 2021.
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438410/all/Dipeptidyl_peptidase__DPP__4_inhibitors_and_glucagon_like_peptide__GLP__1_analogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus:_Cochrane_systematic_review
Dipeptidyl-peptidase (DPP)-4 Inhibitors and Glucagon-like Peptide (GLP)-1 Analogues for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in People at Increased Risk for the Development of Type 2 Diabetes Mellitus: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 March 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438410/all/Dipeptidyl_peptidase__DPP__4_inhibitors_and_glucagon_like_peptide__GLP__1_analogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus: Cochrane systematic review
ID - 438410
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438410/all/Dipeptidyl_peptidase__DPP__4_inhibitors_and_glucagon_like_peptide__GLP__1_analogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
